A2M and Alzheimer disease: Ray et al. [130] examined a variety of plasma-based proteins and developed an algorithm that accurately classified AD based on the measurement of 18 plasma signaling protein profiles including alpha-1-antitrypsin, complement factor H, alpha-2-macroglobulin, apolipoprotein J, apolipoprotein A-I.